Showing results (1721-1730 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|June 20, 2020
Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med ProjectBissan Audeh, Florelle Bellet, Marie-Noëlle Beyens, et al.
Drug Safety|June 20, 2020
The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in EnglandRebecca K Webster, G James Rubin
Drug Safety|May 6, 2020
Critical Assessment of Pharmacokinetic Drug-Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis TreatmentVijayabhaskar Veeravalli, Ranjeet P Dash, Jennifer A Thomas, et al.
Drug Safety|April 17, 2020
Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of HealthcareElena Rocca, Rani Lill Anjum
Drug Safety|June 17, 2015
DNA Barcoding and Pharmacovigilance of Herbal MedicinesHugo J de Boer, Mihael C Ichim, Steven G Newmaster
Drug Safety|September 2, 2025
Leveraging Large Language Models in Extracting Drug Safety Information from Prescription Drug LabelsUndina Gisladottir, Michael Zietz, Sophia Kivelson, et al.
Drug Safety|May 27, 2015
Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From EthiopiaWoldesellassie M Bezabhe, Luke R Bereznicki, Leanne Chalmers, et al.
Drug Safety|May 16, 2021
Enhancing Pharmacovigilance from the US Experience: Current Practices and Future OpportunitiesVeronique F Kugener, Eric S Freedland, Kenneth I Maynard, et al.
Drug Safety|August 4, 2021
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month ReportToyotaka Iguchi, Hikari Umeda, Michie Kojima, et al.
Drug Safety|May 29, 1999
Comparative tolerability of second generation antihistaminesF Horak, U P Stübner
Pageof 309